Gossamer Bio, Inc.

Closed
300 Pasteur Dr
Stanford, CA 94305

Gossamer Bio, Inc. is a biotechnology company based in Stanford, California, focusing on the development of innovative therapies for patients with severe diseases, including pulmonary arterial hypertension. Their research is exemplified by the PROSERA Study, a Phase 3 clinical trial investigating the safety and effectiveness of an inhaled investigational product called seralutinib.

The PROSERA Study aims to explore the underlying mechanisms of pulmonary arterial hypertension by targeting specific pathways related to inflammation, proliferation, and fibrosis. By doing so, Gossamer Bio seeks to advance treatment options for adults living with this rare and progressive condition.

Generated from the website

Own this business?
See a problem?

You might also like

United StatesCaliforniaStanfordGossamer Bio, Inc.